New drug combo aims to tame painful muscle condition

This study is testing if adding an injectable drug called sarilumab to a standard steroid treatment works better for controlling polymyalgia rheumatica (PMR) than the steroid treatment alone. It will involve 300 adults with early or recently flared PMR. Participants will receive either sarilumab or a placebo injection every two weeks for a year, along with a gradually decreasing dose of prednisone, to see which approach leads to longer-lasting symptom relief.